Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy

被引：0
|
作者：
Anna Rydén
Fiona Blackhall
Hye Ryun Kim
Rathi N. Pillai
Lauren Braam
Mona L. Martin
Andrew Walding
机构：
[1] AstraZeneca Gothenburg,Division of Molecular and Clinical Cancer Sciences
[2] University of Manchester,Department of Medical Oncology, Yonsei Cancer Center
[3] The Christie NHS Foundation Trust,Department of Hematology and Medical Oncology, School of Medicine
[4] Yonsei University College of Medicine,undefined
[5] Winship Cancer Institute of Emory University,undefined
[6] Health Research Associates Inc.,undefined
[7] AstraZeneca R&D,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2017年 / 10卷
关键词：
Epidermal Growth Factor Receptor; Initial Interview; Poor Appetite; Bothersome Symptom; Transcript Database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：593 / 603
页数：10
相关论文
共 50 条
  • [1] Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy
    Ryden, Anna
    Blackhall, Fiona
    Kim, Hye Ryun
    Pillai, Rathi N.
    Braam, Lauren
    Martin, Mona L.
    Walding, Andrew
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2017, 10 (05): : 593 - 603
  • [2] Patient experience of symptoms and side effects when treated with AZD9291 for advanced non-small-cell lung cancer: A qualitative interview sub-study
    Ryden, A.
    Braam, L.
    Martin, M.
    Walding, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S221 - S221
  • [3] Osimertinib for non-small-cell Lung Cancer
    Alakus, Hakan
    Zander, Thomas
    Bruns, Christiane
    ONKOLOGE, 2018, 24 (02): : 174 - 176
  • [4] Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib
    Thein, K.
    Swarup, S.
    Ball, S.
    Quirch, M.
    Vorakunthada, Y.
    Khan, S.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S904 - S904
  • [5] Capturing patients' overall experience of HER2-mutationpositive non-small-cell lung cancer in a clinical trial: a qualitative interview substudy
    Zettl, Heiko
    Ryden, Anna
    Racine, Catherine
    van den Bos, Marjolein
    Fragoso, Rita
    Rohrbacher, Maren
    Ingelgaard, Anders
    QUALITY OF LIFE RESEARCH, 2024, 33 : S210 - S210
  • [6] Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
    Soria, J. -C.
    Ohe, Y.
    Vansteenkiste, J.
    Reungwetwattana, T.
    Chewaskulyong, B.
    Lee, K. H.
    Dechaphunkul, A.
    Imamura, F.
    Nogami, N.
    Kurata, T.
    Okamoto, I.
    Zhou, C.
    Cho, B. C.
    Cheng, Y.
    Cho, E. K.
    Voon, P. J.
    Planchard, D.
    Su, W. -C.
    Gray, J. E.
    Lee, S. -M.
    Hodge, R.
    Marotti, M.
    Rukazenkov, Y.
    Ramalingam, S. S.
    Boyer, Michael
    Lee, Chee
    Hughes, Brett
    O'Byrne, Kenneth
    Briggs, Peter
    Milward, Michael
    John, Thomas
    Demedts, Ingel
    Vansteenkiste, Johan
    Bustin, Frederique
    Barrios, Carlos Henrique
    Timcheva, Constanta
    Butts, Charles
    Goss, Glenwood
    Juergens, Rosalyn
    Leighl, Natasha
    Cheng, Susanna
    Burkes, Ronald
    Zhou, Caicun
    Zhang, Helong
    Shu, Yongqian
    Cheng, Ying
    Zhou, Qing
    Li, Wei
    Feng, Guosheng
    He, Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 113 - 125
  • [7] Patient Perspectives and Side-Effects Experience on Chemotherapy of Non-Small Cell Lung Cancer: A Qualitative Study
    Zubair, Hafiz Muhammad
    Khan, Muhammad Arslan
    Gulzar, Faisal
    Alkholief, Musaed
    Malik, Abdul
    Akhtar, Suhail
    Sharif, Ali
    Akhtar, Muhammad Furqan
    Abbas, Muhammad
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 449 - 460
  • [8] Advanced Non-Small-Cell Lung Cancer
    Kwon, Hyun W.
    Ham, Soo-Youn
    Shin, Sang W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1997 - +
  • [9] Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
    Rodier, Thomas
    Puszkiel, Alicja
    Cardoso, Evelina
    Balakirouchenane, David
    Narjoz, Celine
    Arrondeau, Jennifer
    Fallet, Vincent
    Khoudour, Nihel
    Guidi, Monia
    Vidal, Michel
    Decleves, Xavier
    Csajka, Chantal
    Alexandre, Jerome
    Cadranel, Jacques
    Fabre, Elizabeth
    Wislez, Marie
    Goldwasser, Francois
    Blanchet, Benoit
    PHARMACEUTICS, 2022, 14 (09)
  • [10] Patient-Reported Symptoms and Impact of Treatment With Osimertinib Versus Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The AURA3 Trial
    Lee, Chee Khoon
    Novello, Silvia
    Ryden, Anna
    Mann, Helen
    Mok, Tony
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18) : 1853 - +
12345